Topical rosiglitazone is an effective anti-scarring agent in the cornea.
Corneal scarring remains a major cause of blindness world-wide, with limited treatment options, all of which have side-effects. Here, we tested the hypothesis that topical application of Rosiglitazone, a Thiazolidinedione and ligand of peroxisome proliferator activated receptor gamma (PPARγ), can ef...
Tallennettuna:
| Päätekijät: | , , , , , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Public Library of Science (PLoS)
2013-01-01
|
| Sarja: | PLoS ONE |
| Linkit: | http://europepmc.org/articles/PMC3733781?pdf=render |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|